The present invention relates to a substantially crystalline and free solid state form of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid (Form I), pharmaceutical compositions thereof, and methods of treatment therewith.
本发明涉及一种3-(6-(1-(2,2-二
氟苯并[d][1,3]二噁英-5-基)环丙基羧酰胺)-3-
甲基吡啶-2-基)
苯甲酸(Form I)的晶体和自由固态形式,以及其制备的药物组合物和治疗方法。